The role of probiotics in tissue engineering and regenerative medicine

References

• 1. Golchin A, Rekabgardan M, Taheri RA, Nourani MR. Promotion of cell-based therapy: special focus on the cooperation of mesenchymal stem cell therapy and gene therapy for clinical trial studies. In: Advances in Experimental Medicine and Biology (Volume 1119). Springer New York LLC, 103–118 (2018).
  Google Scholar
• 2. Golchin A, Shams F, Basiri A et al. Combination therapy of stem cell-derived exosomes and biomaterials in the wound healing. Stem Cell Rev. Reports 2021. 18(6), 1–20 (2022).
  MedlineGoogle Scholar
• 3. Salgado AJ, Oliveira JM, Martins A et al. Tissue engineering and regenerative medicine: past, present, and future. Int. Rev. Neurobiol. 108, 1–33 (2013).
  Medline CASGoogle Scholar
• 4. Sinha A, Sagar S, Madhumathy M, Osborne WJ. Probiotic bacteria in wound healing; an in-vivo study. Iran. J. Biotechnol. 17(4), 11–15 (2019).
  Google Scholar
• 5. L J, C V, S I et al. Probiotics or pro-healers: the role of beneficial bacteria in tissue repair. Wound Repair Regen. 25(6), 912–922 (2017).
  MedlineGoogle Scholar
• 6. Al-Yassir F, Khoder G, Sugathan S, Saseedharan P, Al Menhali A, Karam SM. Modulation of stem cell progeny by probiotics during regeneration of gastric mucosal erosions. Biology (Basel). 10(7), 596 (2021).
  Medline CASGoogle Scholar
• 7. Radu N, Roman V, Tănăsescu C. Biomaterials obtained from probiotic consortia of microorganisms. Potential applications in regenerative medicine. Mol. Cryst. Liq. Cryst. 628(1), 115–123 (2016).
  CASGoogle Scholar
• 8. Kechagia M, Basoulis D, Konstantopoulou S et al. Health benefits of probiotics: a review. ISRN Nutr. 2013, 1–7 (2013).
  Google Scholar
• 9. Abatenh E, Gizaw B, Tsegay Z, Tefera G, Aynalem E. Health benefits of probiotics. 0(0), 17–27 (2018).
  Google Scholar
• 10. Markowiak P, Ślizewska K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients. 9(9), 1021 (2017).
  MedlineGoogle Scholar
• 11. Martin Manuel P, Elena B, Carolina MG, Gabriela P. Oral probiotics supplementation can stimulate the immune system in a stress process. J. Nutr. Intermed. Metab. 8, 29–40 (2017).
  Google Scholar
• 12. Ashraf R, Vasiljevic T, Day SL, Smith SC, Donkor ON. Lactic acid bacteria and probiotic organisms induce different cytokine profile and regulatory T cells mechanisms. J. Funct. Foods. 6(1), 395–409 (2014).
  CASGoogle Scholar
• 13. Aavani F, Biazar E, Heshmatipour Z, Arabameri N, Kamalvand M, Nazbar A. Applications of bacteria and their derived biomaterials for repair and tissue regeneration. Regen. Med. 16(6), 581–605 (2021).
  CASGoogle Scholar
• 14. Golchin A, Hosseinzadeh S, Jouybar A et al. Wound healing improvement by curcumin-loaded electrospun nanofibers and BFP-MSCs as a bioactive dressing. Polym. Adv. Technol. 31(7), 1519–1531 (2020).
  CASGoogle Scholar
• 15. Golchin A, Shams F, Kangari P, Azari A, Hosseinzadeh S. Regenerative medicine: injectable cell-based therapeutics and approved products. Adv. Exp. Med. Biol. 1237, 75–95 (2020).
  Medline CASGoogle Scholar
• 16. Yang L, Han Z, Chen C et al. Novel probiotic-bound oxidized Bletilla striata polysaccharide-chitosan composite hydrogel. Mater. Sci. Eng. C. 117, 111265 (2020).
  Medline CASGoogle Scholar
• 17. Joy J, Pereira J, Aid-Launais R et al. Gelatin – oxidized carboxymethyl cellulose blend based tubular electrospun scaffold for vascular tissue engineering. Int. J. Biol. Macromol. 107, 1922–1935 (2018).
  Medline CASGoogle Scholar
• 18. Vågesjö E, Öhnstedt E, Mortier A et al. Accelerated wound healing in mice by on-site production and delivery of CXCL12 by transformed lactic acid bacteria. Proc. Natl Acad. Sci. 115(8), 1895–1900 (2018).
  MedlineGoogle Scholar
• 19. Lukic J, Chen V, Strahinic I et al. Probiotics or pro-healers the role of beneficial bacteria in tissue repair.
  Google Scholar
• 20. Rodrigues KL, Gaudino Caputo LR, Tavares Carvalho JC, Evangelista J, Schneedorf JM. Antimicrobial and healing activity of kefir and kefiran extract. Int. J. Antimicrob. Agents. 25(5), 404–408 (2005).
  Medline CASGoogle Scholar
• 21. Huseini HF, Rahimzadeh G, Fazeli MR, Mehrazma M, Salehi M. Evaluation of wound healing activities of kefir products. Burns 38(5), 719–723 (2012).
  MedlineGoogle Scholar
• 22. Roudsari MR, Karimi R, Sohrabvandi S, Mortazavian AM. Health effects of probiotics on the skin. Crit. Rev. Food Sci. Nutr. 55(9), 1219–1240 (2015).
  MedlineGoogle Scholar
• 23. Bindurani S. Review: probiotics in dermatology. J. Ski. Sex. Transm. Dis. 1(2), 66–71 (2019).
  Google Scholar
• 24. Tagliari E, Campos LF, Campos AC, Costa-Casagrande TA, de Noronha L. Effect of probiotic oral administration on skin wound healing in rats. Arq. Bras. Cir. Dig. 32(3), (2019).
  MedlineGoogle Scholar
• 25. Khan MAA, Hussain Z, Ali S, Qamar Z, Imran M, Hafeez FY. Fabrication of electrospun probiotic functionalized nanocomposite scaffolds for infection control and dermal burn healing in a mice model. 5(11), 6109–6116 (2019).
  Google Scholar
• 26. Shavandi A, Saeedi P, Gérard P, Jalalvandi E, Cannella D, Bekhit AE-D. The role of microbiota in tissue repair and regeneration. J. Tissue Eng. Regen. Med. 14(3), 539–555 (2020).
  Medline CASGoogle Scholar
• 27. Manuel J, Molina P. The effect of probioitc treatment on life history allocation, skin regeneration and immunity of ambystoma mexicanum. Southeastern Louisiana University (2019).
  Google Scholar
• 28. Liu K, Catchmark JM. Bacterial cellulose/hyaluronic acid nanocomposites production through co-culturing gluconacetobacter hansenii and lactococcus lactis in a two-vessel circulating system. Bioresour. Technol. 290, 121715 (2019).
  Medline CASGoogle Scholar
• 29. Nicoletti G, Corbella M, Jaber O, Marone P, Scevola D, Faga A. Non-pathogenic microflora of a spring water with regenerative properties. Biomed. Reports. 3(6), 758–762 (2015).
  Medline CASGoogle Scholar
• 30. Al-Ghazzewi FH, Tester RF. Impact of prebiotics and probiotics on skin health. Benef. Microbes. 5(2), 99–107 (2014).
  Medline CASGoogle Scholar
• 31. Deng L, Zhang H. Recent advances in probiotics encapsulation by electrospinning. ES Food Agrofor. 2, 3–12 (2020).
  Google Scholar
• 32. Ashoori Y, Mohkam M, Heidari R et al. Development and in vivo characterization of probiotic lysate-treated chitosan nanogel as a novel biocompatible formulation for wound healing. Biomed Res. Int. 2020, (2020).
  MedlineGoogle Scholar
• 33. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLOS Biol. 14(8), e1002533 (2016).
  MedlineGoogle Scholar
• 34. Bäckhed F, Ding H, Wang T et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. 101(44), 15718–15723 (2004).
  MedlineGoogle Scholar
• 35. LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr. Opin. Biotechnol. 24(2), 160–168 (2013).
  Medline CASGoogle Scholar
• 36. Endt K, Stecher B, Chaffron S et al. The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal salmonella diarrhea. PLOS Pathog. 6(9), e1001097 (2010).
  MedlineGoogle Scholar
• 37. S M, W J, A A, TA O, EF S, F K. Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect. Immun. 75(5), 2399–2407 (2007).
  MedlineGoogle Scholar
• 38. Liu G, Ren W, Fang J et al. l-Glutamine and l-arginine protect against enterotoxigenic Escherichia coli infection via intestinal innate immunity in mice. Amino Acids. 49(12), 1945–1954 (2017).
  Medline CASGoogle Scholar
• 39. Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U, Schmidt MA. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair. Cell. Microbiol. 9(3), 804–816 (2007).
  Medline CASGoogle Scholar
• 40. Bermúdez-Humarán LG, Motta JP, Aubry C et al. Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci. Microb. Cell Fact. 14(1), (2015).
  Google Scholar
• 41. Steidler L, Hans W, Schotte L et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science (80-.). 289(5483), 1352–1355 (2000).
  Medline CASGoogle Scholar
• 42. Kumar M, Yadav AK, Verma V et al. Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects. Future Microbiol. 11(4), 585–600 (2016).
  CASGoogle Scholar
• 43. Vandenbroucke K, De Haard H, Beirnaert E et al. Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis. Mucosal Immunol. 3(1), 49–56 (2010).
  Medline CASGoogle Scholar
• 44. Karthik L, Kumar G, Keswani T, Bhattacharyya A, Sarath Chandar S, Bhaskara Rao KV. Protease inhibitors from marine actinobacteria as a potential source for antimalarial compound. PLOS ONE. 9(3), e90972 (2014).
  Medline CASGoogle Scholar
• 45. Péan N, Doignon I, Garcin I et al. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice. Hepatology 58(4), 1451–1460 (2013).
  Medline CASGoogle Scholar
• 46. Cuenca S, Sanchez E, Santiago A et al. Microbiome composition by pyrosequencing in mesenteric lymph nodes of rats with CCl4-induced cirrhosis. J. Innate Immun. 6(3), 263–271 (2014).
  Medline CASGoogle Scholar
• 47. Rayes N, Pilarski T, Stockmann M, Bengmark S, Neuhaus P, Seehofer D. Effect of pre- and probiotics on liver regeneration after resection: a randomised, double-blind pilot study. Benef. Microbes. 3(3), 237–244 (2012).
  Medline CASGoogle Scholar
• 48. Nardone G, Compare D, Liguori E et al. Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury. Am. J. Physiol. - Gastrointest. Liver Physiol. 299(3), G669–G676 (2010).
  Medline CASGoogle Scholar
• 49. Wang Y, Kirpich I, Liu Y et al. Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am. J. Pathol. 179(6), 2866–2875 (2011).
  Medline CASGoogle Scholar
• 50. Wang Y, Liu Y, Kirpich I et al. Lactobacillus rhamnosus GG reduces hepatic TNFα production and inflammation in chronic alcohol-induced liver injury. J. Nutr. Biochem. 24(9), 1609–1615 (2013).
  Medline CASGoogle Scholar
• 51. Håkansson Å, Bränning C, Molin G et al. Blueberry husks and probiotics attenuate colorectal inflammation and oncogenesis, and liver injuries in rats exposed to cycling DSS-treatment. PLOS ONE. 7(3), e33510 (2012).
  MedlineGoogle Scholar
• 52. Xie Y, Chen H, Zhu B et al. Effect of intestinal microbiota alteration on hepatic damage in rats with acute rejection after liver transplantation. Microb. Ecol. 68(4), 871–880 (2014).
  Medline CASGoogle Scholar
• 53. Kirpich IA, Solovieva NV, Leikhter SN et al. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol 42(8), 675–682 (2008).
  Medline CASGoogle Scholar
• 54. Schepper JD, Irwin R, Kang J et al. Probiotics in gut-bone signaling. Underst. gut-bone Signal. axis 225–247 (2017).
  Google Scholar
• 55. Hernandez CJ, Guss JD, Luna M, Goldring SR. Links between the microbiome and bone. J. Bone Miner. Res. 31(9), 1638–1646 (2016).
  MedlineGoogle Scholar
• 56. Parvaneh K, Jamaluddin R, Karimi G, Erfani R. Effect of probiotics supplementation on bone mineral content and bone mass density. Sci. World J. 2014, (2014).
  Google Scholar
• 57. Yan FF, Murugesan GR, Cheng HW. Effects of probiotic supplementation on performance traits, bone mineralization, cecal microbial composition, cytokines and corticosterone in laying hens. Animal. 13(1), 33–41 (2019).
  Medline CASGoogle Scholar
• 58. Collins FL, Irwin R, Bierhalter H et al. Lactobacillus reuteri 6475 increases bone density in intact females only under an inflammatory setting. PLOS ONE. 11(4), e0153180 (2016).
  MedlineGoogle Scholar
• 59. Rodrigues FC, Castro ASB, Rodrigues VC et al. Yacon flour and Bifidobacterium longum modulate bone health in rats. J. Med. Food. 15(7), 664–670 (2012).
  Medline CASGoogle Scholar
• 60. Tomofuji T, Ekuni D, Azuma T et al. Supplementation of broccoli or Bifidobacterium longum–fermented broccoli suppresses serum lipid peroxidation and osteoclast differentiation on alveolar bone surface in rats fed a high-cholesterol diet. Nutr. Res. 32(4), 301–307 (2012).
  Medline CASGoogle Scholar
• 61. Mutuş R, Kocabağli N, Alp M, Acar N, Eren M, Gezen ŞŞ. The effect of dietary probiotic supplementation on tibial bone characteristics and strength in broilers. Poult. Sci. 85(9), 1621–1625 (2006).
  Medline CASGoogle Scholar
• 62. Chiang S-S, Pan T-M. Beneficial effects of Lactobacillus paracasei subsp. paracasei NTU 101 and its fermented products. Appl. Microbiol. Biotechnol. 93(3), 903–916 (2012).
  Medline CASGoogle Scholar
• 63. Kim JG, Lee E, Kim SH, Whang KY, Oh S, Imm J-Y. Effects of a Lactobacillus casei 393 fermented milk product on bone metabolism in ovariectomised rats. Int. Dairy J. 19(11), 690–695 (2009).
  CASGoogle Scholar
• 64. Narva M, Collin M, Lamberg-Allardt C et al. Effects of long-term intervention with Lactobacillus helveticus-fermented milk on bone mineral density and bone mineral content in growing rats. Ann. Nutr. Metab. 48(4), 228–234 (2004).
  Medline CASGoogle Scholar
• 65. Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J. Pediatr. Gastroenterol. Nutr. 36(2), 223–227 (2003).
  MedlineGoogle Scholar
• 66. Levi YL de AS, Picchi RN, Silva EKT et al. Probiotic administration increases mandibular bone mineral density on rats exposed to cigarette smoke inhalation. Braz. Dent. J. 30(6), 634–640 (2019).
  MedlineGoogle Scholar
• 67. Parvaneh K, Ebrahimi M, Sabran MR et al. Probiotics (Bifidobacterium longum) increase bone mass density and upregulate Sparc and Bmp-2 genes in rats with bone loss resulting from ovariectomy. Biomed Res. Int. 2015, (2015).
  MedlineGoogle Scholar
• 68. Wu S, Lei L, Bao C et al. An injectable and antibacterial calcium phosphate scaffold inhibiting Staphylococcus aureus and supporting stem cells for bone regeneration. Mater. Sci. Eng. C. 120, 111688 (2021).
  Medline CASGoogle Scholar
• 69. Tan L, Fu J, Feng F et al. Engineered probiotics biofilm enhances osseointegration via immunoregulation and anti-infection. Sci. Adv. 6(46), eaba5723 (2020).
  Medline CASGoogle Scholar
• 70. Karska-Wysocki B, Bazo M, Smoragiewicz W. Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA). Microbiol. Res. 165(8), 674–686 (2010).
  MedlineGoogle Scholar
• 71. Ghanbari M, Jami M, Kneifel W, Domig KJ. Antimicrobial activity and partial characterization of bacteriocins produced by lactobacilli isolated from Sturgeon fish. Food Control. 32(2), 379–385 (2013).
  CASGoogle Scholar
• 72. González A, Sabio L, Hurtado C et al. Entrapping living probiotics into collagen scaffolds: a new class of biomaterials for antibiotic-free therapy of bacterial vaginosis. Adv. Mater. Technol. 5(7), 2000137 (2020).
  CASGoogle Scholar
• 73. Mullick P, Das G, Aiyagari R. Probiotic bacteria cell surface-associated protein mineralized hydroxyapatite incorporated in porous scaffold: in vitro evaluation for bone cell growth and differentiation. Mater. Sci. Eng. C. 126, 112101 (2021).
  Medline CASGoogle Scholar
• 74. Fan J, Yang X, Li J et al. Spermidine coupled with exercise rescues skeletal muscle atrophy from D-gal-induced aging rats through enhanced autophagy and reduced apoptosis via AMPK-FOXO3a signal pathway. Oncotarget. 8(11), 17475–17490 (2017).
  MedlineGoogle Scholar
• 75. Bindels LB, Delzenne NM. Muscle wasting: the gut microbiota as a new therapeutic target? Int. J. Biochem. Cell Biol. 45(10), 2186–2190 (2013).
  Medline CASGoogle Scholar
• 76. Wu CS, Wei Q, Wang H et al. Protective effects of ghrelin on fasting-induced muscle atrophy in aging mice. Journals Gerontol. - Ser. A Biol. Sci. Med. Sci. 75(4), 621–630 (2020).
  Medline CASGoogle Scholar
• 77. Cheng LH, Cheng SH, Wu CC et al. Lactobacillus paracasei PS23 dietary supplementation alleviates muscle aging via ghrelin stimulation in D-galactose-induced aging mice. J. Funct. Foods. 85, 104651 (2021).
  CASGoogle Scholar
• 78. Harnett JE, Pyne DB, McKune AJ, Penm J, Pumpa KL. Probiotic supplementation elicits favourable changes in muscle soreness and sleep quality in rugby players. J. Sci. Med. Sport. 24(2), 195–199 (2021).
  MedlineGoogle Scholar
• 79. Jäger R, Shields KA, Lowery RP et al. Probiotic Bacillus coagulans GBI-30, 6086 reduces exercise-induced muscle damage and increases recovery. PeerJ. 2016(7), e2276 (2016).
  Google Scholar
• 80. Townsend JR, Bender D, Vantrease WC et al. Effects of probiotic (Bacillus subtilis de111) supplementation on immune function, hormonal status, and physical performance in division i baseball players. Sports. 6(3), 70 (2018).
  MedlineGoogle Scholar
• 81. Cruz-Jentoft AJ, Dawson Hughes B, Scott D, Sanders KM, Rizzoli R. Nutritional strategies for maintaining muscle mass and strength from middle age to later life: a narrative review. Maturitas. 132, 57–64 (2020).
  MedlineGoogle Scholar
• 82. Jäger R, Zaragoza J, Purpura M et al. Probiotic administration increases amino acid absorption from plant protein: a placebo-controlled, randomized, double-blind, multicenter, crossover study. Probiotics Antimicrob. Proteins. 12(4), 1330–1339 (2020).
  Medline CASGoogle Scholar
• 83. Pan W, Kang Y. Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies. Int. Urol. Nephrol. 50(2), 289–299 (2018).
  Medline CASGoogle Scholar
• 84. Di Cerbo A, Palmieri B, Aponte M, Morales-Medina JC, Iannitti T. Mechanisms and therapeutic effectiveness of lactobacilli. J. Clin. Pathol. 69(3), 187–203 (2016).
  MedlineGoogle Scholar
• 85. Anders HJ, Andersen K, Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int. 83(6), 1010–1016 (2013).
  Medline CASGoogle Scholar
• 86. Rukavina Mikusic NL, Kouyoumdzian NM, Choi MR. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis. Pflugers Arch. Eur. J. Physiol. 472(3), 303–320 (2020).
  MedlineGoogle Scholar
• 87. Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J. Am. Soc. Nephrol. 25(4), 657–670 (2014).
  Medline CASGoogle Scholar
• 88. Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am. J. Nephrol. 39(3), 230–237 (2014).
  Medline CASGoogle Scholar
• 89. Gryp T, Huys GRB, Joossens M, Biesen W Van, Glorieux G, Vaneechoutte M. Isolation and quantification of uremic toxin precursor-generating gut bacteria in chronic kidney disease patients. Int. J. Mol. Sci. 21(6), 1986 (2020).
  Medline CASGoogle Scholar
• 90. Vaziri ND, Wong J, Pahl M et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 83(2), 308–315 (2013).
  MedlineGoogle Scholar
• 91. Watanabe H, Miyamoto Y, Honda D et al. P-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int. 83(4), 582–592 (2013).
  Medline CASGoogle Scholar
• 92. Sun CY, Chang SC, Wu MS. Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition. PLOS ONE. 7(3), e34026 (2012).
  Medline CASGoogle Scholar
• 93. Ranganathan N, Ranganathan P, Friedman EA et al. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv. Ther. 27(9), 634–647 (2010).
  MedlineGoogle Scholar
• 94. Borges NA, Carmo FL, Stockler-Pinto MB et al. Probiotic supplementation in chronic kidney disease: a double-blind, randomized, placebo-controlled trial. J. Ren. Nutr. 28(1), 28–36 (2018).
  Medline CASGoogle Scholar
• 95. Koppe L, Mafra D, Fouque D. Probiotics and chronic kidney disease. Kidney Int. 88(5), 958–966 (2015).
  Medline CASGoogle Scholar
• 96. Jia L, Jia Q, Yang J, Jia R, Zhang H. Efficacy of probiotics supplementation on chronic kidney disease: a systematic review and meta-analysis. Kidney Blood Press. Res. 43(5), 1623–1635 (2018).
  Medline CASGoogle Scholar
• 97. Thongprayoon C, Kaewput W, Hatch ST et al. Effects of probiotics on inflammation and uremic toxins among patients on dialysis: a systematic review and meta-analysis. Dig. Dis. Sci. 64(2), 469–479 (2019).
  Medline CASGoogle Scholar
• 98. Di Iorio BR, Rocchetti MT, De Angelis M et al. Nutritional therapy modulates intestinal microbiota and reduces serum levels of total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease (Medika study). J. Clin. Med. 8(9), 1424 (2019).
  MedlineGoogle Scholar
• 99. Rocchetti MT, Di Iorio BR, Vacca M et al. Ketoanalogs' effects on intestinal microbiota modulation and uremic toxins serum levels in chronic kidney disease (Medika2 study). J. Clin. Med. 10(4), 1–18 (2021).
  Google Scholar
• 100. Dehghani H, Heidari F, Mozaffari-Khosravi H, Nouri-Majelan N, Dehghani A. Synbiotic supplementations for Azotemia in patients with chronic kidney disease: a randomized controlled trial. Iran. J. Kidney Dis. 10(6), 351–357 (2016).
  MedlineGoogle Scholar
• 101. Sabetkish N, Sabetkish S, Mohseni MJ, Kajbafzadeh AM. Prevention of renal scarring in acute pyelonephritis by probiotic therapy: an experimental study. Probiotics Antimicrob. Proteins. 11(1), 158–164 (2019).
  Medline CASGoogle Scholar
• 102. Prasetyo RV, Surono I, Soemyarso NA et al. Lactobacillus plantarum IS-10506 promotes renal tubular regeneration in pyelonephritic rats. Benef. Microbes. 11(1), 59–66 (2020).
  Medline CASGoogle Scholar
• 103. Wynn SG. Probiotics in veterinary practice. J. Am. Vet. Med. Assoc. 234(5), 606–613 (2009).
  MedlineGoogle Scholar
• 104. Den Besten G, Van Eunen K, Groen AK, Venema K, Reijngoud D-J, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54(9), 2325–2340 (2013).
  MedlineGoogle Scholar
• 105. Cosola C, De Angelis M, Rocchetti MT et al. Beta-glucans supplementation associates with reduction in P-cresyl sulfate levels and improved endothelial vascular reactivity in healthy individuals. PLOS ONE. 12(1), e0169635 (2017).
  MedlineGoogle Scholar
• 106. Li L, Ma L, Fu P. Gut microbiota-derived short-chain fatty acids and kidney diseases. Drug Des. Devel. Ther. 11, 3531–3542 (2017).
  Medline CASGoogle Scholar
• 107. Pluznick JL. Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors. Kidney Int. 90(6), 1191–1198 (2016).
  Medline CASGoogle Scholar
• 108. Siciliano RA, Mazzeo MF. Molecular mechanisms of probiotic action: a proteomic perspective. Curr. Opin. Microbiol. 15(3), 390–396 (2012).
  Medline CASGoogle Scholar
• 109. Wang IK, Wu YY, Yang YF et al. The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial. Benef. Microbes. 6(4), 423–430 (2015).
  MedlineGoogle Scholar
• 110. Shariaty Z, Shan GRM, Farajollahi M, Amerian M, Pour NB. The effects of probiotic supplement on hemoglobin in chronic renal failure patients under hemodialysis: a randomized clinical trial. J. Res. Med. Sci. 22(3), (2017).
  MedlineGoogle Scholar
• 111. Peng J, Xiao X, Hu M, Zhang X. Interaction between gut microbiome and cardiovascular disease. Life Sci. 214, 153–157 (2018).
  Medline CASGoogle Scholar
• 112. Thushara RM, Gangadaran S, Solati Z, Moghadasian MH. Cardiovascular benefits of probiotics: a review of experimental and clinical studies. Food Funct. 7(2), 632–642 (2016).
  Medline CASGoogle Scholar
• 113. Lye HS, Kuan CY, Ewe JA, Fung WY, Liong MT. The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int. J. Mol. Sci. 10(9), 3755–3775 (2009).
  Medline CASGoogle Scholar
• 114. Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC. Mechanisms of action of probiotics: recent advances. Inflamm. Bowel Dis. 15(2), 300–310 (2009).
  Medline CASGoogle Scholar
• 115. Wu ZX, Li SF, Chen H et al. The changes of gut microbiota after acute myocardial infarction in rats. PLOS ONE. 12(7), e0180717 (2017).
  MedlineGoogle Scholar
• 116. Higashikawa F, Noda M, Awaya T et al. Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial. Eur. J. Clin. Nutr. 70(5), 582–587 (2016).
  Medline CASGoogle Scholar
• 117. Inoue K, Shirai T, Ochiai H et al. Blood-pressure-lowering effect of a novel fermented milk containing γ-aminobutyric acid (GABA) in mild hypertensives. Eur. J. Clin. Nutr. 57(3), 490–495 (2003).
  Medline CASGoogle Scholar
• 118. Lam V, Su J, Hsu A, Gross GJ, Salzman NH, Baker JE. Intestinal microbial metabolites are linked to severity of myocardial infarction in rats. PLOS ONE. 11(8), e0160840 (2016).
  MedlineGoogle Scholar
• 119. Moludi J, Saiedi S, Ebrahimi B, Alizadeh M, Khajebishak Y, Ghadimi SS. Probiotics supplementation on cardiac remodeling following myocardial infarction: a single-center double-blind clinical study. J. Cardiovasc. Transl. Res. 14(2), 299–307 (2021).
  MedlineGoogle Scholar
• 120. Chan YK, El-Nezami H, Chen Y, Kinnunen K, Kirjavainen PV. Probiotic mixture VSL# 3 reduce high fat diet induced vascular inflammation and atherosclerosis in ApoE−/− mice. Amb Express. 6(1), 1–8 (2016).
  MedlineGoogle Scholar
• 121. Gan XT, Ettinger G, Huang CX et al. Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circ. Hear. Fail. 7(3), 491–499 (2014).
  MedlineGoogle Scholar
• 122. Azuma M, Takahashi K, Fukuda T et al. Taurine attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac myocytes. Eur. J. Pharmacol. 403(3), 181–188 (2000).
  Medline CASGoogle Scholar
• 123. Costanza AC, Moscavitch SD, Faria Neto HCC, Mesquita ET. Probiotic therapy with Saccharomyces boulardii for heart failure patients: a randomized, double-blind, placebo-controlled pilot trial. Int. J. Cardiol. 179, 348–350 (2015).
  MedlineGoogle Scholar
• 124. Eckburg PB, Bik EM, Bernstein CN et al. Microbiology: diversity of the human intestinal microbial flora. Science (80-.). 308(5728), 1635–1638 (2005).
  MedlineGoogle Scholar
• 125. Tang WHW, Wang Z, Kennedy DJ et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ. Res. 116(3), 448–455 (2014).
  MedlineGoogle Scholar
• 126. Stubbs JR, House JA, Ocque AJ et al. Serum Trimethylamine-N-Oxide is Elevated in CKD and correlates with coronary atherosclerosis burden. J. Am. Soc. Nephrol. 27(1), 305–313 (2016).
  Medline CASGoogle Scholar
• 127. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut 35(Suppl. 1), S35–S38 (1994).
  Medline CASGoogle Scholar
• 128. Ufnal M, Jazwiec R, Dadlez M, Drapala A, Sikora M, Skrzypecki J. Trimethylamine-N-Oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats. Can. J. Cardiol. 30(12), 1700–1705 (2014).
  MedlineGoogle Scholar
• 129. Tang TWH, Chen HC, Chen CY et al. Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair. Circulation 139(5), 647–659 (2019).
  Medline CASGoogle Scholar
• 130. Zilla P, Von Oppell U, Deutsch M. The endothelium: a key to the future. J. Card. Surg. 8(1), 32–60 (1993).
  Medline CASGoogle Scholar
• 131. Meinhart JG, Deutsch M, Fischlein T, Howanietz N, Fröschl A, Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann. Thorac. Surg. 71(5), S327–S331 (2001).
  Medline CASGoogle Scholar
• 132. Crovesy L, Ostrowski M, Ferreira DMTP, Rosado EL, Soares-Mota M. Effect of Lactobacillus on body weight and body fat in overweight subjects: a systematic review of randomized controlled clinical trials. Int. J. Obes. 41(11), 1607–1614 (2017).
  CASGoogle Scholar
• 133. Koppinger MP, Lopez-Pier MA, Skaria R, Harris PR, Konhilas JP. Lactobacillus reuteri attenuates cardiac injury without lowering cholesterol in low-density lipoprotein receptor-deficient mice fed standard chow. Am. J. Physiol. - Hear. Circ. Physiol. 319(1), H32–H41 (2020).
  Medline CASGoogle Scholar
• 134. Lam VY, Su J, Koprowski S et al. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J. 26(4), 1727–1735 (2012).
  Medline CASGoogle Scholar
• 135. Sefidgari-Abrasi S, Karimi P, Roshangar L et al. Lactobacillus plantarum and Inulin: therapeutic agents to enhance cardiac ob receptor expression and suppress cardiac apoptosis in type 2 diabetic rats. J. Diabetes Res. 2020, (2020).
  MedlineGoogle Scholar
• 136. De Smet I, Van Hoorde L, De Saeyer N, Vande Woestyne M, Verstraete W. In vitro study of bile salt hydrolase (BSH) activity of BSH isogenic lactobacillus plantarum 80 strains and estimation of cholesterol lowering through enhanced BSH activity. Microb. Ecol. Health Dis. 7(6), 315–329 (1994).
  Google Scholar
• 137. Begley M, Hill C, Gahan CGM. Bile salt hydrolase activity in probiotics. Appl. Environ. Microbiol. 72(3), 1729–1738 (2006).
  Medline CASGoogle Scholar
• 138. Klein A, Friedrich U, Vogelsang H, Jahreis G. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Eur. J. Clin. Nutr. 62(5), 584–593 (2008).
  Medline CASGoogle Scholar
• 139. Mohan JC, Arora R, Khalilullah M. Preliminary observations on effect of Lactobacillus sporogenes on serum lipid levels in hypercholesterolemic patients. Indian J. Med. Res. - Sect. B Biomed. Res. Other Than Infect. Dis. 92(DEC.), 431–432 (1990).
  Medline CASGoogle Scholar
• 140. Lin SY, Ayres JW, Winkler W, Sandine WE. Lactobacillus effects on cholesterol: in vitro and in vivo results. J. Dairy Sci. 72(11), 2885–2899 (1989).
  Medline CASGoogle Scholar
• 141. Abd El-Gawad IA, El-Sayed EM, Hafez SA, El-Zeini HM, Saleh FA. The hypocholesterolaemic effect of milk yoghurt and soy-yoghurt containing bifidobacteria in rats fed on a cholesterol-enriched diet. Int. Dairy J. 15(1), 37–44 (2005).
  Google Scholar
• 142. Kumar M, Nagpal R, Kumar R et al. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp. Diabetes Res. 2012, (2012).
  Google Scholar
• 143. Xiao JZ, Kondo S, Takahashi N et al. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J. Dairy Sci. 86(7), 2452–2461 (2003).
  Medline CASGoogle Scholar
• 144. Du Toit M, Franz CMAP, Dicks LMT et al. Characterisation and selection of probiotic lactobacilli for a preliminary minipig feeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture content. Int. J. Food Microbiol. 40(1–2), 93–104 (1998).
  MedlineGoogle Scholar
• 145. Liu YW, Liong MT, Tsai YC. New perspectives of Lactobacillus plantarum as a probiotic: the gut-heart-brain axis. J. Microbiol. 56(9), 601–613 (2018).
  MedlineGoogle Scholar
• 146. Ting WJ, Kuo WW, Hsieh DJY et al. Heat killed lactobacillus reuteri GMNL-263 reduces fibrosis effects on the liver and heart in high fat diet-hamsters via TGF-β suppression. Int. J. Mol. Sci. 16(10), 25881–25896 (2015).
  Medline CASGoogle Scholar
• 147. Ettinger G, Burton JP, Gloor GB, Reid G. Lactobacillus rhamnosus GR-1 attenuates induction of hypertrophy in cardiomyocytes but not through secreted protein MSP-1 (p75). PLOS ONE. 12(1), e0168622 (2017).
  MedlineGoogle Scholar
• 148. Xu H, Wang J, Cai J et al. Protective effect of lactobacillus rhamnosus gg and its supernatant against myocardial dysfunction in obese mice exposed to intermittent hypoxia is associated with the activation of nrf2 pathway. Int. J. Biol. Sci. 15(11), 2471–2483 (2019).
  Medline CASGoogle Scholar
• 149. Suganya K, Koo BS. Gut–brain axis: role of gut microbiota on neurological disorders and how probiotics/prebiotics beneficially modulate microbial and immune pathways to improve brain functions. Int. J. Mol. Sci. 21(20), 1–29 (2020).
  Google Scholar
• 150. Sudo N, Chida Y, Aiba Y et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J. Physiol. 558(1), 263–275 (2004).
  Medline CASGoogle Scholar
• 151. Mayer EA. Gut feelings: the emerging biology of gut–brain communication. Nat. Rev. Neurosci. 12(8), 453–466 (2011).
  Medline CASGoogle Scholar
• 152. Wang H, Lee IS, Braun C, Enck P. Effect of probiotics on central nervous system functions in animals and humans: a systematic review. J. Neurogastroenterol. Motil. 22(4), 589–605 (2016).
  Medline CASGoogle Scholar
• 153. Bravo JA, Forsythe P, Chew MV et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl Acad. Sci. U. S. A. 108(38), 16050–16055 (2011).
  Medline CASGoogle Scholar
• 154. O'Sullivan E, Barrett E, Grenham S et al. BDNF expression in the hippocampus of maternally separated rats: Does Bifidobacterium breve 6330 alter BDNF levels? Benef. Microbes. 2(3), 199–207 (2011).
  MedlineGoogle Scholar
• 155. Ait-Belgnaoui A, Durand H, Cartier C et al. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 37(11), 1885–1895 (2012).
  Medline CASGoogle Scholar
• 156. Zhu S, Jiang Y, Xu K et al. The progress of gut microbiome research related to brain disorders. J. Neuroinflammation. 17(1), 1–20 (2020).
  Medline CASGoogle Scholar
• 157. Braniste V, Al-Asmakh M, Kowal C et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 6(263), 263ra158–263ra158 (2014).
  MedlineGoogle Scholar
• 158. Saulnier DM, Ringel Y, Heyman MB et al. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes. 4(1), 17–27 (2013).
  MedlineGoogle Scholar
• 159. Azm SAN, Djazayeri A, Safa M et al. Lactobacilli and bifidobacteria ameliorate memory and learning deficits and oxidative stress in β-amyloid (1–42) injected rats. Appl. Physiol. Nutr. Metab. 43(7), 718–726 (2018).
  MedlineGoogle Scholar
• 160. Liang S, Wang T, Hu X et al. Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience 310, 561–577 (2015).
  Medline CASGoogle Scholar
• 161. Wang T, Hu X, Liang S et al. Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rats. Benef. Microbes. 6(5), 707–717 (2015).
  Medline CASGoogle Scholar
• 162. Akbari E, Asemi Z, Daneshvar Kakhaki R et al. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: a randomized, double-blind and controlled trial. Front. Aging Neurosci. 8, 256 (2016).
  MedlineGoogle Scholar
• 163. Abraham D, Feher J, Scuderi GL et al. Exercise and probiotics attenuate the development of Alzheimer's disease in transgenic mice: role of microbiome. Exp. Gerontol. 115, 122–131 (2019).
  Medline CASGoogle Scholar
• 164. Fang X. Microbial treatment: the potential application for Parkinson's disease. Neurol. Sci. 40(1), 51–58 (2019).
  MedlineGoogle Scholar
• 165. Bonfili L, Cecarini V, Berardi S et al. Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels. Sci. Rep. 7(1), 1–21 (2017).
  Medline CASGoogle Scholar
• 166. Cassani E, Privitera G, Pezzoli G et al. Use of probiotics for the treatment of constipation in Parkinson's disease patients. Minerva Gastroenterol. Dietol. 57(2), 117–121 (2011).
  Medline CASGoogle Scholar
• 167. Barichella M, Pacchetti C, Bolliri C et al. Probiotics and prebiotic fiber for constipation associated with Parkinson disease. Neurology 87(12), 1274–1280 (2016).
  Medline CASGoogle Scholar
• 168. Georgescu D, Ancusa OE, Georgescu LA, Ionita I, Reisz D. Nonmotor gastrointestinal disorders in older patients with Parkinson's disease: is there hope? Clin. Interv. Aging. 11, 1601–1608 (2016).
  Medline CASGoogle Scholar
• 169. Pierantozzi M, Pietroiusti A, Sancesario G et al. Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson's disease patients. Neurol. Sci. 22(1), 89–91 (2001).
  Medline CASGoogle Scholar
• 170. Liu WH, Chuang HL, Huang YT et al. Alteration of behavior and monoamine levels attributable to Lactobacillus plantarum PS128 in germ-free mice. Behav. Brain Res. 298, 202–209 (2016).
  Medline CASGoogle Scholar
• 171. Pinto-Sanchez MI, Hall GB, Ghajar K et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology 153(2), 448–459.e8 (2017).
  MedlineGoogle Scholar
• 172. Khalighi AR, Khalighi MR, Behdani R et al. Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO) - A pilot study. Indian J. Med. Res. 140(5), 604–608 (2014).
  Medline CASGoogle Scholar
• 173. Gazerani P. Probiotics for Parkinson's disease. Int. J. Mol. Sci. 20(17), 4121 (2019).
  Medline CASGoogle Scholar
• 174. Lavasani S, Dzhambazov B, Nouri M et al. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLOS ONE. 5(2), e9009 (2010).
  MedlineGoogle Scholar
• 175. Kwon HK, Kim GC, Kim Y et al. Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response. Clin. Immunol. 146(3), 217–227 (2013).
  Medline CASGoogle Scholar
• 176. Umbrello G, Esposito S. Microbiota and neurologic diseases: potential effects of probiotics. J. Transl. Med. 14(1), 1–11 (2016).
  MedlineGoogle Scholar
• 177. Brandi J, Cheri S, Manfredi M et al. Exploring the wound healing, anti-inflammatory, anti-pathogenic and proteomic effects of lactic acid bacteria on keratinocytes. Sci. Rep. 10(1), 1–14 (2020).
  MedlineGoogle Scholar
• 178. Lew LC, Gan CY, Liong MT. Dermal bioactives from lactobacilli and bifidobacteria. Ann. Microbiol. 63(3), 1047–1055 (2013).
  CASGoogle Scholar
• 179. Corbett GA, Crosby DA, McAuliffe FM. Probiotic therapy in couples with infertility: a systematic review. Eur. J. Obstet. Gynecol. Reprod. Biol. 256, 95–100 (2021).
  Medline CASGoogle Scholar
• 180. Proctor LM, Chhibba S, Mcewen J et al. The NIH human microbiome project. Hum. Microbiota How Microb. Communities Affect Heal. Dis. 19(12), 1–50 (2013).
  Google Scholar
• 181. Ravel J, Gajer P, Abdo Z et al. Vaginal microbiome of reproductive-age women. Proc. Natl Acad. Sci. USA 108(Suppl. 1), 4680–4687 (2011).
  Medline CASGoogle Scholar
• 182. Ohri M, Prabha V. Isolation of a sperm-agglutinating factor from Staphylococcus aureus isolated from a woman with unexplained infertility. Fertil. Steril. 84(5), 1539–1541 (2005).
  MedlineGoogle Scholar
• 183. Bhandari P, Rishi P, Prabha V. Positive effect of probiotic Lactobacillus plantarum in reversing LPS-induced infertility in a mouse model. J. Med. Microbiol. 65(5), 345–350 (2016).
  Medline CASGoogle Scholar
• 184. Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, Reid G. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect. 8(12–13), 2772–2776 (2006).
  Medline CASGoogle Scholar
• 185. Younis N, Mahasneh A. Probiotics and the envisaged role in treating human infertility. Middle East Fertil. Soc. J. 25(1), 1–9 (2020).
  Google Scholar
• 186. Barbonetti A, Cinque B, Vassallo MRC et al. Effect of vaginal probiotic lactobacilli on in vitro-induced sperm lipid peroxidation and its impact on sperm motility and viability. Fertil. Steril. 95(8), 2485–2488 (2011).
  Medline CASGoogle Scholar
• 187. Pascual LM, Daniele MB, Giordano W, Pájaro MC, Barberis IL. Purification and partial characterization of novel bacteriocin L23 produced by Lactobacillus fermentum L23. Curr. Microbiol. 56(4), 397–402 (2008).
  Medline CASGoogle Scholar
• 188. Bhandari P, Prabha V. Evaluation of profertility effect of probiotic Lactobacillus plantarum 2621 in a murine model. Indian J. Med. Res. 142(JULY), 79–84 (2015).
  Medline CASGoogle Scholar
• 189. Ibrahim HAM, Zhu Y, Wu C et al. Erratum: selenium-enriched probiotics improves murine male fertility compromised by high fat diet (Biological Trace Element Research DOI: 10.1007/s12011-011-9308-2). Biol. Trace Elem. Res. 147(1–3), 428 (2012).
  CASGoogle Scholar
• 190. Chen XL, Gong LZ, Xu JX. Antioxidative activity and protective effect of probiotics against high-fat diet-induced sperm damage in rats. Animal. 7(2), 287–292 (2013).
  Medline CASGoogle Scholar
• 191. Helli B, Kavianpour M, Ghaedi E, Dadfar M, Haghighian HK. Probiotic effects on sperm parameters, oxidative stress index, inflammatory factors and sex hormones in infertile men. Hum. Fertil. 1–9 (2020).
  Google Scholar
• 192. Poutahidis T, Springer A, Levkovich T et al. Probiotic microbes sustain youthful serum testosterone levels and testicular size in aging mice. PLOS ONE. 9(1), e84877 (2014).
  MedlineGoogle Scholar
• 193. Kaufmann U, Domig KJ, Lippitsch CI et al. Ability of an orally administered lactobacilli preparation to improve the quality of the neovaginal microflora in male to female transsexual women. Eur. J. Obstet. Gynecol. Reprod. Biol. 172(1), 102–105 (2014).
  MedlineGoogle Scholar
• 194. Birse KD, Kratzer K, Zuend CF et al. The neovaginal microbiome of transgender women post-gender reassignment surgery. Microbiome. 8(1), 1–13 (2020).
  MedlineGoogle Scholar
• 195. McNerney MP, Doiron KE, Ng TL, Chang TZ, Silver PA. Theranostic cells: emerging clinical applications of synthetic biology. Nat. Rev. Genet. 22(11), 730–746 (2021).
  Medline CASGoogle Scholar
• 196. Khan S, Hauptman R, Kelly L. Engineering the microbiome to prevent adverse events: challenges and opportunities. Annu. Rev. Pharmacol. Toxicol. 61, 159–179 (2021).
  Medline CASGoogle Scholar
• 197. Gomaa EZ. Human gut microbiota/microbiome in health and diseases: a review. Antonie van Leeuwenhoek, Int. J. Gen. Mol. Microbiol. 113(12), 2019–2040 (2020).
  MedlineGoogle Scholar
• 198. Peirce JM, Alviña K. The role of inflammation and the gut microbiome in depression and anxiety. J. Neurosci. Res. 97(10), 1223–1241 (2019).
  Medline CASGoogle Scholar
• 199. Qiu W, Zhou Y, Li Z et al. Application of antibiotics/antimicrobial agents on dental caries. Biomed Res. Int. 2020, (2020).
  Google Scholar
• 200. Harper A, Vijayakumar V, Ouwehand AC et al. Viral infections, the microbiome, and probiotics. Front. Cell. Infect. Microbiol. 925 (2021).
  Google Scholar
• 201. Lorente-picón M, Laguna A. New avenues for parkinson's disease therapeutics: disease-modifying strategies based on the gut microbiota. Biomolecules. 11(3), 1–39 (2021).
  Google Scholar
• 202. Spacova I, Dodiya HB, Happel AU et al. Future of probiotics and prebiotics and the implications for early career researchers. Front. Microbiol. 11, 1400 (2020).
  MedlineGoogle Scholar
• 203. Alemzadeh E, Oryan A. Application of encapsulated probiotics in health care. J. Exp. Pathol. 1(1), (2020).
  Google Scholar
• 204. Zhu Y, Wang Z, Bai L, Deng J, Zhou Q. Biomaterial-based encapsulated probiotics for biomedical applications: current status and future perspectives. Mater. Des. 210, 110018 (2021).
  CASGoogle Scholar
• 205. Mettu S, Hathi Z, Athukoralalage S et al. Perspective on constructing cellulose-hydrogel-based gut-like bioreactors for growth and delivery of multiple-strain probiotic bacteria. J. Agric. Food Chem. 69(17), 4946–4959 (2021).
  Medline CASGoogle Scholar
• 206. Ngo N, Choucair K, Creeden JF et al. Bifidobacterium spp: the promising trojan horse in the era of precision oncology. Futur. Oncol. 15(33), 3861–3876 (2019).
  CASGoogle Scholar
• 207. Liao N, Pang B, Jin H et al. Potential of lactic acid bacteria derived polysaccharides for the delivery and controlled release of oral probiotics. J. Control. Release. 323, 110–124 (2020).
  Medline CASGoogle Scholar
• 208. Li S, Jiang W, Zheng C et al. Oral delivery of bacteria: basic principles and biomedical applications. J. Control. Rel. 327, 801–833 (2020).
  Medline CASGoogle Scholar
• 209. Thakur AK, Singh I. Formulation strategies for the oral delivery of probiotics: a review. Biointerface Res. Appl. Chem. 9(5), 4327–4333 (2019).
  CASGoogle Scholar
• 210. Gautier T, Gall SD-L, Sweidan A et al. Next-generation probiotics and their metabolites in covid-19. Microorganisms. 9(5), 941 (2021).
  Medline CASGoogle Scholar
• 211. Ailioaie LM, Litscher G. Probiotics, photobiomodulation, and disease management: controversies and challenges. Int. J. Mol. Sci. 22(9), 4942 (2021).
  Medline CASGoogle Scholar
• 212. Andrade JC, Almeida D, Domingos M et al. Commensal obligate anaerobic bacteria and health: production, storage, and delivery strategies. Front. Bioeng. Biotechnol. 8, 1–23 (2020).
  MedlineGoogle Scholar
• 213. Cheng WY, Wu CY, Yu J. The role of gut microbiota in cancer treatment: friend or foe? Gut 69(10), 1867–1876 (2020).
  Medline CASGoogle Scholar
• 214. Sedighi M, Zahedi Bialvaei A, Hamblin MR et al. Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities. Cancer Med. 8(6), 3167–3181 (2019).
  MedlineGoogle Scholar
• 215. Liu J, Liu C, Yue J. Radiotherapy and the gut microbiome: facts and fiction. Radiat. Oncol. 16(1), 1–15 (2021).
  MedlineGoogle Scholar
• 216. Zhou Z, Chen X, Sheng H et al. Engineering probiotics as living diagnostics and therapeutics for improving human health. Microb. Cell Fact. 19(1), 1–12 (2020).
  MedlineGoogle Scholar
• 217. Ke X, Walker A, Haange S-B et al. Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice. Mol. Metab. 22, 96–109 (2019).
  Medline CASGoogle Scholar